[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
February 1989

Hepatectomy Prolongs Survival of Mice With Induced Liver Metastases

Author Affiliations

From the Department of Surgery, State University of New York at Buffalo (Drs Castillo and Doerr), and Roswell Park Memorial Institute, Buffalo (Mr Paolini, and Drs Cohen and Goldrosen).

Arch Surg. 1989;124(2):167-169. doi:10.1001/archsurg.1989.01410020037005
Abstract

• Resection of hepatic metastases from colorectal cancer has been shown to prolong survival in some patients. Whether this results from a reduction of tumor burden or is an indirect effect mediated by hepatectomy is questionable. Male C57BL/6Ros 8-week-old mice underwent ileocolic vein injection of a suspension of 0.3 mL of 2×105 viable liver-derived murine (MCA-38) colonic adenocarcinoma cells. This model produces hepatic metastases in all lobes of the liver. At 7,14, or 21 days after tumor injection, mice were randomized to receive either 42% resection of the liver or laparotomy alone. Survival in the animals with hepatectomy was significantly prolonged when the hepatectomy was performed 14 or 21 days after tumor injection.

(Arch Surg 1989;124:167-169)

References
1.
Hughes KS, Sugarbaker PH:  Resection of the liver for metastatic solid tumor , in Rosenberg SA (ed): Surgical Treatment of Metastatic Cancer . Philadelphia, JB Lippincott, 1987, pp 125-128.
2.
Ono M, Tanako N, Kunzo O:  Complete regression of mouse hepatoma transplanted after partial hepatectomy: The immunological mechanism of such regression . Cancer Res 1986;46:5049-5053.
3.
Paschkis KE, Canatarow A, Stasney J:  Tumor growth in partially hepatectomized rats . Cancer Res 1955;15:579-582.
4.
Stolar CJ, Anderson KD:  Growth of mouse hepatoma following liver resection . J Pediatr Surg 1980;15:513-516.Article
5.
Goldrosen MH, Paolini N, Holyoke ED:  Description of a murine model of experimental hepatic metastases . JNCI 1986;77:823-828.
6.
American Cancer Society: 1985 Cancer Facts and Figures . New York, American Cancer Society, 1985, p 9.
7.
Taylor FW:  Cancer of the colon and rectum: A study of routes of metastases and death . Surgery 1962;52:305-308.
8.
Rosenberg SA, Spiess P, Lafreniere R:  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes . Science 1986;233:1318-1321.Article
9.
Wagner JS, Adson MA, van Herrden JA, et al:  Natural history of hepatic metastases from colorectal cancer: Comparison with resective treatment . Ann Surg 1984;199:502-508.Article
10.
Kemeny MM, Goldberg DA, Browning S, et al:  Experience with regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries: A prospective randomized study . Cancer 1985;55:1265-1270.Article
11.
Woodington GF, Waugh JM:  Results of resection of metastatic tumors of the liver . Am J Surg 1963;105:24-29.Article
12.
Kortz WJ, Meyers WC, Hanks JB, et al:  Hepatic resection for metastatic cancer . Ann Surg 1984;199:182-186.Article
13.
Fortner JG, Silua JS, Golbey RB, et al:  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer . Ann Surg 1984;199:306-324.Article
14.
Cady B, McDermott WV:  Major hepatic resection for metachronous metastases from colon cancer . Ann Surg 1985;201:205-209.Article
15.
Iwatsuki S, Esquivel CO, Gorden R, et al:  Liver resection for metastatic colorectal cancer . Surgery 1986;100:804-810.
16.
Craddock CG, Nakai GS, Fukuta H, et al:  Proliferative activity of the lymphocytic tissues of rats as studied with tritium-labeled thymidine . J Exp Med 1964;120:389-412.Article
17.
Ono M, Tanaka N, Orita K:  Activation of NK activity and autoreactive cytotoxicity after hepatectomy . Acta Med Okayama 1984;38:207-213.
18.
Fisher B, Fisher ER:  Experimental studies of factors influencing hepatic metastasis: II. Effect of partial hepatectomy . Cancer 1959;12:929-931.Article
19.
Koike A, Sahyun S, Long ML:  The fate of Ehrlich cells injected into the portal system . Cancer Res 1963;16:716-720.
20.
Lafreniere R, Rosenberg SA:  Successful immunotherapy of murine experimental hepatic metastases with LAK cells and IL-2 . Cancer Res 1985;45:3735-3741.
21.
Kopper L, Van Hanh T, Lapis K, et al:  Experimental model for liver metastases formation using Lewis lung tumor . J Cancer Res Clin Oncol 1982;103:31-38.Article
22.
Doerr RJ, Castillo MH, Paolini N, et al: Induction of cytokines in murine non-parenchymal liver cells by partial hepatectomy . Abstract of the Society of Surgical Oncology, New Orleans, (May 22) -25, 1988.
×